作为发现的决策:在一家领先的精密瘤学服务中对临床研究进行审查
Alberto Cambrosio1, Jonah Campbell1, Alexander E Drilon2
1Department of Social Studies of Medicine, McGill University, Montreal, Quebec, Canada.
Sociology of health & illness
|October 5, 2023
概括
这项研究探讨了在临床试验中对实验性癌症药物的决策是如何做出的. 它揭示了这些选择如何通过整合科学数据与患者护理需求来塑造精确瘤学.
科学领域:
- 在瘤学瘤学.
- 翻译研究是翻译研究.
- 卫生系统科学 卫生系统科学
背景情况:
- 早期药物开发服务对于推进癌症疗法至关重要.
- 临床试验的选择决定了未来精密瘤治疗的管道.
- 在这种情况下理解决策对于优化药物开发和患者护理至关重要.
研究的目的:
- 分析在药物开发早期选择实验药物的决策过程.
- 探索科学和临床因素如何融入这些决策.
- 了解这些决定在塑造精密瘤学领域的作用.
主要方法:
- 在早期药物开发服务中进行的实地研究.
- 在一个翻译研究单元内分析集体决策实践.
- 审查在决策中使用的正式工具和临时估值策略.
主要成果:
- 决策涉及技术科学和以患者为导向的临床考虑的混合.
- 这些实践有助于生物医学知识的机构"资产化".
- 这个过程重构了精密瘤学的社会物质生态系统.
结论:
- 药物开发早期的决策对分子导向治疗的可用性有很大影响.
- 这些实践是不断发展的"变体诊所"和精确瘤学的核心.
- 这项研究强调了各种组件在执行精密瘤学的动态相互作用.
更多相关视频
07:03Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
942
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
相关概念视频
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
137
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
137
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
